It’s no secret that the biotech and pharma industries are highly regulated and for very good reason. We have an
Category: Midsize with a Big Vision
Better, Bolder Science: Across the bench collaboration in epigenetics
Dr. Lindsey Rodrigues, a biomedical engineer and cancer biologist by training, and Lindsey Eichinger, who has a background in veterinary sciences and cell biology, are two scientists at Ipsen who are leading the exploration of epigenetics – a new frontier for cancer research and the future of cancer care.
Closing Gaps in Cancer Care – Together
Dr. Amauri Soares, VP Head of Early Development & Innovation Oncology at Ipsen uses
music to explain the importance of understanding the genetics of cancer and how the emerging field of epigenetics could unlock a new paradigm for precision medicine.
Epizyme welcome to Ipsen
Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.